These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22716468)

  • 1. Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation.
    Shah PP; Mashru RC
    Pharm Dev Technol; 2010 Jun; 15(3):276-85. PubMed ID: 22716468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(3):1025-30. PubMed ID: 18770047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of artemether microparticles for bitter taste masking.
    Shah PP; Mashru RC; Rane YM; Badhan AC
    Acta Pharm; 2008 Dec; 58(4):379-92. PubMed ID: 19103573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
    Rahman Z; Zidan AS; Berendt RT; Khan MA
    Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology.
    Shah PP; Mashru RC; Thakkar AR; Badhan AC
    J Pharm Pharmacol; 2008 Apr; 60(4):421-7. PubMed ID: 18380913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.
    Patel AR; Vavia PR
    AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of primaquine phosphate taste-masked rapidly disintegrating tablet.
    Shah PP; Mashru RC
    J Pharm Pharmacol; 2008 Oct; 60(10):1279-85. PubMed ID: 18812020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
    Mukne AP; Nagarsenker MS
    AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres.
    Devrim B; Bozkir A; Canefe K
    Acta Pol Pharm; 2011; 68(4):593-9. PubMed ID: 21796942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental designed optimisation and stability evaluation of dry suspensions with artemisinin derivatives for paediatric use.
    Gabriëls M; Plaizier-Vercammen J
    Int J Pharm; 2004 Sep; 283(1-2):19-34. PubMed ID: 15363498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.
    Wei Y; Nedley MP; Bhaduri SB; Bredzinski X; Boddu SH
    AAPS PharmSciTech; 2015 Apr; 16(2):455-65. PubMed ID: 25361901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins.
    Chandra Sekhara Rao G; Satish Kumar M; Mathivanan N; Bhanoji Rao ME
    Pharmazie; 2004 Aug; 59(8):627-30. PubMed ID: 15378853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.